Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: nephrologists, renal pathologists, and researchers who want the latest evidence‑based updates on rare glomerular diseases—particularly C3 glomerulopathy (C3G)
+ Sample video: contact me for sample video
+ Information:
C3G & Immune Complex MPGN Updates 2026
October 02, 2026
Columbia University Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high-yield challenging scenarios in managing C3G and Immune Complex MPGN disease. The half-day conference course is designed to enhance the knowledge of healthcare professionals on pathogenesis, genetics, pathology, and genetic variants associated with C3G disease. Through lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. The course is tailored for healthcare providers specializing in Nephrology and addressing these issues and includes talks, Q&A, and panel discussions.
Learning Objectives
The Columbia University C3G & Immune Complex MPGN Updates 2026 is best for nephrologists, renal pathologists, and researchers who want the latest evidence‑based updates on rare glomerular diseases—particularly C3 glomerulopathy (C3G) and immune complex–mediated membranoproliferative glomerulonephritis (MPGN). It emphasizes translational science, diagnostic advances, and evolving therapeutic strategies.
👩⚕️ Target Audience
- Nephrologists & renal specialists managing patients with rare glomerular diseases.
- Renal pathologists interpreting complex biopsy findings.
- Internal medicine physicians with interest in kidney disease and systemic disorders.
- Researchers & scientists studying complement pathways, immune complex disease, and novel therapeutics.
- Residents & fellows in nephrology or pathology preparing for subspecialty careers.
- Pharmacologists & industry professionals developing targeted therapies for rare kidney disorders.
📚 What Participants Gain
- Pathophysiology updates: complement dysregulation and immune complex mechanisms.
- Diagnostic advances: biopsy interpretation, biomarkers, and genetic testing.
- Therapeutic strategies: immunosuppressive regimens, complement inhibitors, and emerging biologics.
- Case‑based learning: real patient scenarios to sharpen clinical decision‑making.
- Research frontiers: translational science bridging laboratory discoveries with clinical care.
- Guideline integration: evolving standards for rare glomerular disease management.
+ Topics:
- 8:25 Welcome & Introductions Course Directors: Jai Radhakrishnan MD, MS; Andrew S. Bomback MD, MPH
- SESSION 1: MECHANISMS DRIVING COMPLEMENT-MEDIATED GLOMERULAR INJURY
- 8:30 Complement Biology in the Modern Era: From Pathways to Therapeutic Targets Benjamin Wooden MD, Assistant Professor of Medicine, Nephrology, Columbia
- 9:00 Integrated Mechanisms of Injury in C3 Glomerulopathy & Immune Complex MPGN Mariela Navarro-Torres MD, Assistant Professor of Medicine, Nephrology, Columbia
- 9:30 Q&A
- SESSION 2: CONTEMPORARY APPROACHES TO DIAGNOSING COMPLEMENT-MEDIATED GN
- 10:00 Clinical Clues and Early Recognition of C3 Glomerulopathy & Immune Complex-Mediated MPGN Jai Radhakrishnan MD, MS, Professor of Medicine, Nephrology, Columbia
- 10:35 Pathologic Patterns & Biopsy Interpretation in Complement-Driven GN Dominick Santoriello MD, Associate Professor of Pathology & Cell Biology, Columbia
- 11:10 C3 Glomerulopathy and IC-MPGN Advanced Diagnostic Tools: Complement Panels, Genetics & Beyond Andrew S. Bomback MD, MPH, Associate Professor of Medicine, Nephrology, Columbia
- 11:45 Q&A
- SESSION 3: MANAGEMENT, INFECTIOUS RISK & THERAPEUTIC DECISION-MAKING
- 12:00 Evolving Treatment Paradigms: Precision Approaches to C3 Glomerulopathy & Immune Complex MPGN Andrew S. Bomback MD, MPH, Associate Professor of Medicine, Nephrology, Columbia
- 12:30 Infectious Disease Risk Mitigation in Complement-Targeted Therapy Marcus Pereira MD, MPH, Professor of Medicine, Infectious Diseases, Columbia
- 1:00 Challenging Clinical Scenarios: Multidisciplinary Case Discussions Miroslav Sekulic MD, Associate. Professor of Pathology & Cell Biology, Columbia Natasha Freeman MD, MS, Assistant Professor of Medicine, Nephrology, Columbia
- 1:30 Q&A
- 2:00 Adjourn
Reviews
There are no reviews yet.